XML 103 R15.htm IDEA: XBRL DOCUMENT v2.4.1.9
Debt
12 Months Ended
Dec. 31, 2014
Debt Disclosure [Abstract]  
Debt

6. Debt

Debt comprised the following at December 31, 2014 and 2013:

 

(In thousands)

 

Maturity
Dates

 

 

December 31,
2014

 

 

December 31,
2013

 

Unsecured private placement notes

 

 

 

 

 

 

 

 

 

 

 

 

3.86%

 

 

2019-2025

 

 

$

100,000

 

 

$

100,000

 

4.86%

 

 

2017-2023

 

 

 

65,000

 

 

 

65,000

 

5.88%

 

 

2016-2022

 

 

 

40,000

 

 

 

40,000

 

5.69%

 

 

2015-2018

 

 

 

22,857

 

 

 

28,571

 

6.86%

 

 

2015

 

 

 

4,284

 

 

 

8,570

 

Unsecured U.S. bank debt

 

 

2019

 

 

 

20,000

 

 

 

 

Debt of foreign subsidiaries

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured bank debt, foreign currency

 

 

2015

 

 

 

12,043

 

 

 

19,488

 

Unsecured bank term loan, foreign currency

 

 

2021

 

 

 

4,840

 

 

 

 

Secured bank term loan, foreign currency

 

 

2015

 

 

 

2,723

 

 

 

5,843

 

Secured bank debt, foreign currency

 

 

2015

 

 

 

1,638

 

 

 

2,153

 

Unsecured bank debt, U.S. dollars

 

 

2015

 

 

 

546

 

 

 

998

 

Total debt

 

 

 

 

 

$

273,931

 

 

$

270,623

 

Less current maturities

 

 

 

 

 

 

27,034

 

 

 

35,377

 

Long-term debt

 

 

 

 

 

$

246,897

 

 

$

235,246

 

The majority of the Company’s long-term debt financing is composed of unsecured private placement notes issued to insurance companies, totaling $232,141,000 as of December 31, 2014. These notes are denominated in U.S. dollars and have fixed interest rates ranging from 3.86 percent to 6.86 percent. At inception, these notes had final maturities of 12 to 13 years with remaining amortization scheduled from 2015 to 2025.

On July 10, 2014, the Company amended its committed $125,000,000 multi-currency five-year revolving credit agreement.  This unsecured facility is the Company’s primary source of short-term borrowings, which the Company may draw on as needed to finance certain acquisitions, working capital and for general corporate purposes. The amendment extends the maturity date of the original agreement from September 20, 2017 to July 10, 2019. As of December 31, 2014, the Company had outstanding borrowings of $20,000,000 and letters of credit of $2,727,000  under the credit agreement, with $102,273,000 remaining available.

Loans under the amended agreement may be incurred, at the discretion of the Company, with terms to maturity of 1 to 180 days. The Company may choose interest rate options, including (1) LIBOR applicable to each currency plus spreads ranging from 0.975 percent to 1.525 percent, depending on the Company’s leverage ratio or (2) the prime rate plus zero percent to 0.525 percent, depending on the leverage ratio. The amended agreement requires the Company to pay a facility fee ranging from 0.150 percent to 0.350 percent, which also depends on the leverage ratio. The amended agreement requires the maintenance of certain financial ratios and compliance with certain other covenants that are similar to the Company’s existing debt agreements, including net worth, interest coverage and leverage financial covenants and limitations on restricted payments, indebtedness and liens.

At December 31, 2014, European debt included $7,563,000 of bank term loans. One of these term loans, for $4,840,000 matures in 2021 and has a variable interest rate of 90-day EURIBOR plus a spread of 1.30 percent. The other term loan, for $1,815,000, matures in 2016 and has a variable interest rate of 90-day EURIBOR plus a spread of 1.08 percent. The other term loan for, $908,000, matures in 2015 and bears a fixed interest rate of 2.15 percent. At December 31, 2014, debt in Europe also included short-term borrowings of $11,842,000 with variable interest rates of 90-day EURIBOR plus spreads ranging from 0.30 percent and 0.50 percent and short-term borrowings of $1,638,000 with a variable rate comprised of the UK base rate plus a spread of 2.00 percent. The Company’s Philippine subsidiary had short-term borrowings of $747,000, guaranteed by the Company, with a variable interest rate of 30-day LIBOR plus a spread of 1.375 percent. The balance of the Company’s secured foreign debt is secured only by the assets of the respective entities.

The Company’s loan agreements in the U.S., France and the Philippines contain provisions, which, among others, require maintenance of certain financial ratios and place limitations on additional debt, investments and payment of dividends. Based on the loan agreement provisions that place limitations on dividend payments, unrestricted retained earnings (i.e., retained earnings available for dividend distribution) were $88,684,000 and $148,467,000 at December 31, 2014, and 2013, respectively.

Debt at December 31, 2014, matures as follows: $27,034,000 in 2015; $12,723,000 in 2016; $21,405,000 in 2017; $21,406,000 in 2018; $49,977,000 in 2019 and $141,386,000 after 2019. Debt maturing in 2015 includes $12,808,000 of scheduled repayments under long-term debt agreements and $14,226,000 of debt of foreign subsidiaries under short-term working capital loans. These short-term loan agreements are routinely renewed, but could be supplemented or replaced, if necessary, by the Company’s $125,000,000 revolving credit agreement.

Net interest expense for the years ended December 31, 2014, 2013 and 2012, comprised the following:

 

(In thousands)

 

2014

 

 

2013

 

 

2012

 

Interest expense

 

$

12,542

 

 

$

11,104

 

 

$

9,998

 

Interest income

 

 

(262

 

 

(57

)

 

 

(112

)

 

 

 

12,280

 

 

 

11,047

 

 

 

9,886

 

Capitalized interest

 

 

(839

 

 

(689

)

 

 

(287

)

Interest expense, net

 

$

11,441

 

 

$

10,358

 

 

$

9,599